Intra-articular ozone injections for arthritis are one of the best-studied applications of medical ozone, with systematic reviews showing they reduce pain and improve function as effectively as hyaluronic acid or corticosteroid injections in many patients. The treatment is widely used in Europe and gaining traction in the United States as an alternative to repeated steroid shots or knee replacement.
This article covers the evidence, which joints respond best, how it compares to other injection therapies, and what to expect from treatment.
- Systematic reviews of 11+ studies show intra-articular ozone reduces pain (VAS) and improves function (WOMAC) in knee osteoarthritis
- A 2024 meta-analysis found ozone injections comparable to hyaluronic acid for knee OA, with a better safety profile
- Fernandez-Cuadros et al. demonstrated that ozone has both symptomatic and disease-modifying effects on knee OA
- Prolozone therapy (ozone + nutrients) is a related approach with clinical support but limited RCT evidence
- Most patients need 3-5 injection sessions at $100-$300 each
How Ozone Works in Arthritic Joints
Osteoarthritis (OA) involves progressive cartilage breakdown, chronic inflammation, and pain. The joint environment becomes acidic and oxygen-depleted, creating a cycle of damage and inflammation that accelerates cartilage loss.
When medical-grade ozone is injected into an arthritic joint, it triggers several beneficial responses:
- Anti-inflammatory action: Ozone modulates inflammatory cytokines. Research by Fernandez-Cuadros et al. showed that intra-articular ozone reduces IL-6 (a key inflammatory marker) while increasing IGF-1 (an anabolic growth factor that supports cartilage repair)
- Analgesic effect: Ozone increases local endorphin release and modulates pain signaling at the nerve level
- Improved oxygen supply: Ozone enhances local microcirculation and tissue oxygenation, counteracting the hypoxic joint environment
- Cartilage support: The increase in IGF-1 suggests ozone may have anabolic (tissue-building) effects on cartilage, not just symptomatic relief
This last point is particularly significant. Most injection therapies for OA (corticosteroids, hyaluronic acid) are purely symptomatic. If ozone actually supports cartilage metabolism, it could modify disease progression.
The Evidence: Systematic Reviews and Meta-Analyses
Fernandez-Cuadros et al. (2020-2022)
Dr. Marcos Fernandez-Cuadros and colleagues at Hospital Universitario Santa Cristina in Madrid published a series of studies confirming the symptomatic and disease-modifying effects of intra-articular ozone for knee OA.
In a prospective study of 115 patients, ozone treatment decreased:
- VAS pain scores (significant reduction)
- WOMAC-pain subscale
- WOMAC-stiffness subscale
- WOMAC-function subscale
Their 2022 study published in Processes (MDPI) further demonstrated that ozone modulates inflammation through IL-6 reduction and has anabolic effects via IGF-1 upregulation. This dual action sets ozone apart from treatments that only address symptoms.
2024 Meta-Analysis: Ozone vs. Hyaluronic Acid
A 2024 level I meta-analysis published in the European Journal of Orthopaedic Surgery & Traumatology compared intra-articular ozone injections to hyaluronic acid (HA) for knee OA. The findings showed comparable effectiveness between the two approaches, with ozone having a favorable safety profile.
This is meaningful because hyaluronic acid injections cost $300-$800 per session and are an established treatment covered by many insurers. If ozone produces equivalent results at a fraction of the cost, it could become a first-line option.
2019 Systematic Review
A systematic review published in Arthroscopy in 2019 examined randomized controlled trials of oxygen-ozone therapy for knee OA. Across 11 studies published from 2011-2018, the review found consistent evidence that ozone injections improve pain and function. The treatment was well-tolerated with minimal side effects.
“Intra-articular ozone has both symptomatic relief and disease-modifying effects on knee osteoarthritis, reducing inflammatory markers while increasing anabolic growth factors.” – Fernandez-Cuadros et al., Processes (2022)
Ozone vs. Other Injection Therapies
| Treatment | Pain Relief Duration | Cost Per Session | Disease-Modifying? | Key Limitation |
|---|---|---|---|---|
| Ozone injection | 3-6 months | $100-$300 | Possibly (IGF-1 increase) | Limited US availability |
| Corticosteroid | 4-12 weeks | $100-$400 | No (may accelerate cartilage loss) | Limited to 3-4 per year. Cartilage damage risk |
| Hyaluronic acid | 3-6 months | $300-$800 | Minimal | Expensive. Mixed evidence for efficacy |
| PRP (platelet-rich plasma) | 6-12 months | $500-$1,500 | Possibly | Expensive. Results vary by preparation method |
| Prolozone | 3-12 months | $150-$400 | Possibly | Limited RCT evidence |
Prolozone Therapy: Ozone + Nutrients
Prolozone is a technique developed by Dr. Frank Shallenberger that combines ozone gas with a nutrient solution (typically procaine, B vitamins, and sometimes homeopathic anti-inflammatory agents) injected into and around the joint.
The rationale: the nutrient cocktail provides building blocks for tissue repair while the ozone stimulates healing and reduces inflammation. Prolozone is commonly used for knees, hips, shoulders, ankles, and spinal joints.
A study comparing prolotherapy with dextrose to prolozone for knee OA found both approaches produced similar improvements in pain, stiffness, and function. However, the study also found that saline injections with ozone performed similarly to saline without ozone, raising questions about how much of the benefit comes from ozone specifically versus the injection procedure itself.
Despite limited RCT evidence, prolozone has a strong clinical following. No significant side effects have been reported beyond temporary post-injection pain. It may be worth considering for patients who have not responded to conventional injection therapies.
Which Joints Respond Best?
The vast majority of ozone injection research focuses on the knee. However, clinical experience and smaller studies suggest effectiveness in other joints:
- Knee: Best studied. Strong evidence for medial compartment OA and patellofemoral syndrome
- Hip: Limited studies but positive clinical reports. Injection requires ultrasound or fluoroscopic guidance
- Shoulder: Used for rotator cuff-related pain and acromioclavicular OA. Small studies show benefit
- Ankle: Case series show improvement in post-traumatic ankle OA
- Spine: Facet joint ozone injections used for facet-mediated back pain (overlaps with the back pain application of ozone)
What to Expect During Treatment
A typical ozone injection session for arthritis:
- The skin over the joint is cleaned with antiseptic
- Local anesthetic (lidocaine) may be applied
- A needle is inserted into the joint space (often with ultrasound guidance)
- 10-20 mL of ozone-oxygen gas mixture (typically 20-30 mcg/mL) is injected
- You may feel a sensation of fullness or mild pressure in the joint
- The procedure takes 5-15 minutes
Post-injection, you can typically walk immediately and resume normal activities within 24-48 hours. Some patients experience temporary increased pain or swelling for 1-2 days as the ozone stimulates an inflammatory healing response.
Most treatment protocols call for 3-5 injections spaced 1-2 weeks apart. Some patients respond after a single injection. Others require the full series.
Cost and Availability
- Cost per injection: $100-$300 in the US
- Full treatment course (3-5 sessions): $300-$1,500
- Insurance: Not covered in the US
- Availability: Growing but still limited. More common in integrative medicine, naturopathic, and pain management clinics
Compared to knee replacement surgery ($30,000-$50,000 with significant recovery time), ozone injections represent a low-risk, low-cost option worth trying before committing to surgical intervention.
Sources
- Fernandez-Cuadros ME, et al. Intra-articular ozone modulates inflammation and has anabolic effect on knee osteoarthritis. Processes. 2022;10(1):138. doi:10.3390/pr10010138
- Duymus TM, et al. Oxygen-ozone therapy for the treatment of knee osteoarthritis: a systematic review of randomized controlled trials. Arthroscopy. 2020;36(1):277-286. doi:10.1016/j.arthro.2019.05.043
- Singh S, et al. Intra-articular injections of ozone versus hyaluronic acid for knee osteoarthritis: a level I meta-analysis. Eur J Orthop Surg Traumatol. 2024. doi:10.1007/s00590-024-04135-x
- Fernandez-Cuadros ME, et al. Intra-articular ozone modulates inflammation, ameliorates pain and rigidity, improves function and has anabolic effect on knee osteoarthritis: a prospective quasi-experimental study, 115 patients. Rev Assoc Med Bras. 2020;66(6):871-877.
- Hashemi M, et al. The effects of prolotherapy with hypertonic dextrose versus prolozone in patients with knee osteoarthritis. Anesth Pain Med. 2015;5(5):e27585. doi:10.5812/aapm.27585
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
